Reversible MRI abnormalities in mesial temporal lobe epilepsy: a case report

Reversible MRI abnormalities in mesial temporal lobe epilepsy: a case report

Authors

  • Chiara Pizzanelli Clinica Neurologica, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana
  • Lorenzo Caciagli U.O. Neurologia, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana
  • Veronica Bartolami U.O. Neurologia, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana
  • Filippo Sean Giorgi U.O. Neurologia, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana
  • Ilaria Pesaresi U.O. Neuroradiologia, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana
  • Melania Guida U.O. Neurologia, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana
  • Ubaldo Bonuccelli U.O. Neurologia, Università di Pisa e Azienda Ospedaliero-Universitaria Pisana

DOI:

https://doi.org/10.7175/cmi.v7i3.880

Keywords:

Epilepsy, MRI, Reversible abnormalities, Seizures

Abstract

The question regarding  the existence of abnormalities in the neuroimaging exams immediately after status epilecticus or epileptic seizures, but showing complete reversibility after a proper antiepileptic therapy, has long been debated. The first reports attempting to demonstrate their existence date back to the 1980s, and relied upon computed tomography as the imaging method of choice. After the introduction of MRI, a more appropriate characterization of these abnormalities was obtained along with the description of their most frequent features: (a) T2 signal hyperintensity in the white matter and, occasionally, (b) reduced apparent diffusion coefficient (ADC) and increased signal in DWI sequences.

The MRI abnormalities induced by epileptic activity pose a broad differential diagnosis including infections, inflammatory autoimmune encephalopathies, neoplasms. It remains a diagnosis of exclusion and requires proper diagnostic iter in order to reduce the risk of misdiagnosis and unnecessary intervention.

In this case report, a thorough presentation will be outlined about MRI alterations in the left mesial temporal lobe, which resulted completely reversible after a proper antiepileptic therapy.

References

Cianfoni A, Caulo M, Cerase A et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol 2013; 82: 1964-72; http://dx.doi.org/10.1016/j.ejrad.2013.05.020

Sethi PK, Kumar BR, Madan VS et al. Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurosurg Psychiatry 1985; 48: 866-9; http://dx.doi.org/10.1136/jnnp.48.9.866

Goulatia RK, Verma A, Mishra NK et al. Disappearing CT lesions in epilepsy. Epilepsia 1987; 28: 523-7; http://dx.doi.org/10.1111/j.1528-1157.1987.tb03682.x

Dillon W, Brant-Zawadzki M, Sherry RG. Transient computed tomographic abnormalities after focal seizures. AJNR Am J Neuroradiol 1984; 5: 107-9

Henry TR, Drury I, Brunberg JA et al. Focal cerebral magnetic resonance changes associated with partial status epilepticus. Epilepsia 1994; 35: 35-41; http://dx.doi.org/10.1111/j.1528-1157.1994.tb02909.x

Cole AJ. Status epilepticus and periictal imaging. Epilepsia 2004; 45 S4: 72-7; http://dx.doi.org/10.1111/j.0013-9580.2004.04014.x

Szabo K, Poepel A, Pohlmann-Eden B et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain 2005; 128: 1369-76; http://dx.doi.org/10.1093/brain/awh454

Holmes GL. Seizure-induced neuronal injury: animal data. Neurology 2002; 59 S3-6; http://dx.doi.org/10.1212/WNL.59.9_suppl_5.S3

Beghi E, De Maria G, Gobbi G et al. Diagnosis and treatment of the first epileptic seizure: Guidelines of the Italian League Agaist Epilepsy. Epilepsia 2006; 47 (Suppl 5): 2-8; http://dx.doi.org/10.1111/j.1528-1167.2006.00869.x

Smith SJ. EEG in the diagnosis, classification, and management of patients with epilepsy. J Neurol Neurosurg Psychiatry 2005; 76 (S2): 2-7

Gultekin Humayun S, Rosenfeld MR, Voltz R et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481-94; http://dx.doi.org/10.1093/brain/123.7.1481

Glauser T, Ben-Menachem E, Bourgeois B et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013; 54 (3): 551-63; http://dx.doi.org/10.1111/epi.12074

Downloads

Published

2013-10-04

Issue

Vol. 7 No. 3 (2013)

Section

Case report

License

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)